ORGANOGENESIS HOLDINGS INC. Unrecognized Tax Benefits
ORGANOGENESIS HOLDINGS INC. (ORGO) had Unrecognized Tax Benefits of $1.06 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefits · last filed 2026-02-26
- 2025-12-31: Unrecognized Tax Benefits $1.06M.
- 2024-12-31: Unrecognized Tax Benefits $873.00K.
- 2023-12-31: Unrecognized Tax Benefits $1.62M.
- 2022-12-31: Unrecognized Tax Benefits $1.63M.
| Period end | Unrecognized Tax Benefits | Unrecognized Tax Benefits as first filed |
|---|---|---|
| 2025-12-31 | $1.06M 10-K · filed 2026-02-26 | |
| 2024-12-31 | $873.00K 10-K · filed 2026-02-26 | |
| 2023-12-31 | $1.62M 10-K · filed 2026-02-26 | |
| 2022-12-31 | $1.63M 10-K · filed 2026-02-26 | |
| 2021-12-31 | $1.61M 10-K · filed 2025-02-27 | |
| 2020-12-31 | $2.12M 10-K · filed 2024-02-29 | |
| 2019-12-31 | $2.62M 10-K · filed 2023-03-01 | |
| 2018-12-31 | $3.29M 10-K · filed 2022-03-01 | |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $3.49M 10-K · filed 2021-03-16 | $0.00 10-K · filed 2018-03-14 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-11 | |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $3.49M 10-K · filed 2020-03-09 | $0.00 10-K · filed 2017-03-28 |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-18 | |
| 2015-12-31 | $3.66M 10-K · filed 2020-03-09 | $0.00 10-Q · filed 2016-11-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |